Abstract
Introduction
Type 2 diabetes is prevalent among US adults. Lifestyle interventions that modify health behaviours prevent or delay progression to diabetes among individuals at high risk. Despite the well-documented influence of individuals’ social context on their health, evidence-based type 2 diabetes prevention interventions do not systematically incorporate participants’ romantic partners. Involving partners of individuals at high risk for type 2 diabetes in primary prevention may improve engagement and outcomes of programmes. The randomised pilot trial protocol described in this manuscript will evaluate a couple-based lifestyle intervention to prevent type 2 diabetes. The objective of the trial is to describe the feasibility of the couple-based intervention and the study protocol to guide planning of a definitive randomised clinical trial (RCT).
Methods and analysis
We used community-based participatory research principles to adapt an individual diabetes prevention curriculum for delivery to couples. This parallel two-arm pilot study will include 12 romantic couples in which at least one partner (ie, ‘target individual’) is at risk for type 2 diabetes. Couples will be randomised to either the 2021 version of the CDC’s PreventT2 curriculum designed for delivery to individuals (six couples), or PreventT2 Together, the adapted couple-based curriculum (six couples). Participants and interventionists will be unblinded, but research nurses collecting data will be blinded to treatment allocation. Feasibility of the couple-based intervention and the study protocol will be assessed using both quantitative and qualitative measures.
Ethics and dissemination
This study has been approved by the University of Utah IRB (#143079). Findings will be shared with researchers through publications and presentations. We will collaborate with community partners to determine the optimal strategy for communicating findings to community members. Results will inform a subsequent definitive RCT.
Trial registration number
Keywords: PREVENTIVE MEDICINE, DIABETES & ENDOCRINOLOGY, NUTRITION & DIETETICS, PUBLIC HEALTH
STRENGTHS AND LIMITATIONS OF THIS STUDY.
Community-based participatory research principles, including collaborative and equitable partnerships between researchers and community members, were used to adapt the CDC’s National Diabetes Prevention Program (DPP) curriculum, 2021 PreventT2, to be broadly applicable to romantic couples across communities and cultures (ie, in PreventT2 Together).
PreventT2 Together is the first lifestyle intervention to systematically incorporate romantic partners in primary prevention of type 2 diabetes.
This randomised pilot trial of individual versus couple-based diabetes prevention will be carried out in collaboration with an organisation offering the National DPP with ‘Full Recognition’ status through the CDC’s Diabetes Prevention Recognition Program, ensuring those randomised to the individual comparison condition receive the highest quality intervention.
This pilot trial assesses feasibility in a small sample of couples, and will guide a definitive randomised trial. In this larger trial, we intend to recruit a sample with adequate statistical power to detect between-condition differences in health behaviours, physical and mental health, and relationship functioning.
PreventT2 Together is likely only applicable to adults in stable and supportive romantic relationships in which both partners want to make lifestyle changes.
Introduction
Type 2 diabetes was the eighth-leading cause of death in the USA in 2020, and increases risk for the two leading causes of death, cardiovascular disease and cancer.1–3 Nearly 15% of US adults have diabetes and 90%–95% of these individuals have type 2 diabetes, defined by elevated blood glucose or HbA1c values.4 Approximately 11% of individuals at high risk for type 2 diabetes convert to type 2 diabetes annually without intervention.5 6 Individual risk for type 2 diabetes can be determined based on both non-modifiable and modifiable risk factors such as family history, elevated glucose levels and lifestyle.7 Furthermore, people from communities of colour experiencing systemic inequities have higher rates of pre-diabetes and type 2 diabetes compared with white individuals,8 disparities that are expected to increase over time.9 Thus, there is a need for interventions that are broadly applicable across communities, including for people from racial and ethnic groups that have been marginalised.4
Fortunately, lifestyle intervention is efficacious in delaying or preventing progression to type 2 diabetes among individuals at risk.10 In the large-scale NIH-funded Diabetes Prevention Program (DPP) efficacy trial, type 2 diabetes incidence was lower at the end of the 2.8-year active intervention phase among individuals randomised to the lifestyle intervention arm (58% lower incidence) or the metformin (medication) arm (31% lower incidence) compared with those randomised to the placebo control arm.5 Participants randomised to the lifestyle intervention arm improved their health behaviours (eg, physical activity, nutrition) and lost weight during the active intervention phase of the DPP trial. Specifically, 74% of participants in the lifestyle intervention arm achieved the physical activity goal (ie, ≥150 min moderate-to-vigorous physical activity (MVPA) per week) and 50% attained the weight loss goal (ie, ≥7% body weight loss).5 Nonetheless, there is substantial room for improvement, as more than 70% of participants in the individual lifestyle intervention arm did not meet either the physical activity or nutrition change goals of the programme at the end of active treatment, and still half did not meet the weight loss goal.11 However, results from the DPP efficacy trial demonstrate the lasting preventive effects of both the lifestyle intervention and metformin on type 2 diabetes incidence. At 15-year follow-up, the type 2 diabetes incidence rate remained lower in the original lifestyle intervention and metformin conditions compared with the control condition, despite the fact that all participants (across the three arms to which they were originally randomised) were offered group-based lifestyle intervention following the active intervention phase of the DPP.6
Over the past decade, in the largest-scale translation to date, the Centers for Disease Control and Prevention (CDC) has implemented the National DPP, a group-based lifestyle intervention based on the lifestyle intervention arm of the DPP efficacy trial.12 Unfortunately, recruitment and retention rates in the National DPP have been substantially lower than those in the DPP trial, with just 10.4% of individuals who begin the National DPP completing the full year-long intervention.13 Low recruitment and retention rates disproportionately affect men14 and individuals who are members of groups that have been marginalised (eg, individuals identifying as Hispanic or non-Hispanic black, and individuals with low educational attainment or income).15–17 In part due to ineffective participant engagement, health behaviour change goal attainment over the first 4 years of the National DPP was substantially lower than those observed in the lifestyle intervention arm of the DPP. Only 41.8% of National DPP participants met the physical activity goal of at least 150 minutes of MVPA per week, compared with 74% in the DPP efficacy trial.5 13 Similarly, just 35.5% of National DPP participants met the weight loss goal (ie, ≥5% body weight loss), compared with 50% in the DPP efficacy trial, which included a more stringent goal (ie, ≥7% body weight loss).5 13 Similar to engagement challenges, people of colour were significantly less likely to meet the physical activity and weight loss goals compared with non-Hispanic whites.13 Thus, although lifestyle intervention has great promise, further work is needed to extend the reach, engagement and outcomes of the National DPP to more individuals at risk for type 2 diabetes, and particularly members of groups that have been marginalised who have not been effectively reached.
Involving close others in diabetes prevention efforts may increase engagement, outcomes and reach of the National DPP among adults at risk for type 2 diabetes. Across chronic illnesses, interventions delivered to patients and partners together yield superior health improvements compared with interventions delivered to patients alone,18 and relationship processes (eg, support) are related to levels of health behaviours.19 20 For the prevention of type 2 diabetes, there is preliminary evidence suggesting potential benefits of including close others in lifestyle intervention to prevent type 2 diabetes.21 22 For example, individuals who attended the National DPP with another member of their household demonstrated greater engagement and attendance.21 Additionally, in a large-scale translation of the DPP in American Indian and Alaska Native communities, attending with a family support person was associated with significantly reduced risk of retention failure (ie, not attending all sessions or becoming lost to follow-up).23 Similarly, in a healthy lifestyle intervention for African Americans, individuals enrolling with a partner had a 2.95 greater odds of retention (ie, participating in all data collection time points) compared with individuals enrolling alone.24 Involving partners may also address known barriers to National DPP engagement. For example, Lifestyle Coaches indicate that lack of family support within the household is a barrier to participation and lifestyle change in the National DPP.25 National DPP participants primarily from communities that are underserved also identify lack of social support as a barrier to health behaviour change.26 Finally, Lifestyle Coaches with experience delivering the National DPP to individuals and close others identified benefits consistent with these findings (eg, having a partner in lifestyle change, superior outcomes and increased engagement, and positive ‘ripple effects’.)22 Taken together, these findings suggest that participation in lifestyle interventions with a partner may improve retention and engagement, especially for members of groups that have been marginalised. However, despite the preliminary evidence for the benefits of incorporating close others, existing interventions to prevent type 2 diabetes among adults have not systematically involved family members. Results of evaluations of type 2 diabetes management programmes that include romantic partners have been mixed, likely in part due to low methodological quality of the studies.27 28 There are also mixed results reported from trials of lifestyle interventions for couples in which one partner is at risk for a condition other than type 2 diabetes (eg, breast cancer, adverse pregnancy outcomes and cardiac disease).29 30 There is a need for rigorous intervention research that builds on findings from relationship science to better understand type 2 diabetes prevention in a relationship context.
Although systematically involving close others in type 2 diabetes prevention is an important direction, it is critical that this work simultaneously aim to reduce the substantial diabetes disparities, particularly among communities of colour. Given its primary goal of reducing health disparities, community-based participatory research (CBPR) is a particularly promising research orientation to optimise lifestyle interventions.31 32 CBPR focuses on engaging and empowering community members throughout the research process33 by establishing bidirectional relationships between researchers and community members in which power is shared.34 We are not aware of research leveraging the strengths of both relationship science and CBPR to optimise type 2 diabetes prevention, a combination with unique potential to reduce disparities. The formation of a community advisory board (CAB) is a specific CBPR method that empowers stakeholders by soliciting feedback and input on the research.35 As described below, we formed a CAB composed of individuals and a romantic couple with relevant personal and/or professional expertise in diabetes prevention among groups that have been minoritised.36 The CAB provided feedback and recommendations on optimally adapting the CDC’s diabetes prevention curriculum to be delivered to couples across communities.
Although the intervention adaptation team included key stakeholders and the CDC approved the couple-based adaptation as an ‘Alternate Curriculum’ for use in the National DPP, this trial is the first evaluation of the programme. The purpose of this trial is to describe the feasibility of the adapted intervention and the study protocol in preparation for a future definitive randomised clinical trial (RCT). We carefully reviewed and adhered to guidance from the conceptual framework for randomised feasibility and pilot studies37 and the Consolidated Standards of Reporting Trials (CONSORT) extension to pilot and feasibility trials.38 The objectives of this trial are:
To describe the feasibility of the adapted couple-based intervention from the perspectives of (A) participating couples and (B) Lifestyle Coaches delivering the intervention.
To describe the feasibility of the study protocol for use in a definitive trial, with a specific focus on (A) recruitment, (B) randomisation and (C) measurement of key outcome domains.
Methods
Patient and public involvement
Prior to submission of a proposal for extramural funding, in January 2017, the research team collaborated with the University of Utah Clinical and Translational Science Institute (CTSI) Community Collaboration and Engagement Team to conduct a one-time focus group meeting. Participants (n=8) in the focus group included individuals with relevant personal and/or professional expertise from five community organisations within the Salt Lake Valley: Best of Africa, Calvary Baptist Church, the Hispanic Health Care Task Force, the National Tongan American Society of Utah and the Urban Indian Center of Salt Lake. The grant proposal, which integrated feedback from this focus group on the overall research question and planned methods, was funded by the National Institute of Diabetes and Digestive and Kidney Diseases in June 2018.
Once the grant proposal was funded, the team invited former focus group participants as well as other stakeholders with professional and/or personal expertise (eg, National DPP Lifestyle Coaches and Master Trainers, dietitians, community health workers and a married couple coping with type 2 diabetes) to serve as stakeholders on a CAB. The 12-member CAB was racially and ethnically diverse, with at least one member from each of the five organisations described above. See Aguirre et al36 for a detailed description of the CAB members and procedures. All CAB members are invited to contribute as coauthors on project products (including this paper), and are compensated for their time attending CAB meetings and otherwise supporting the project. The CAB met monthly from January 2019 to December 2020 to review the 2016 CDC PreventT2 curriculum and suggest adaptations for couple-based delivery across communities. Although the primary focus of the CAB was on couple-based adaptations to the intervention that would be broadly applicable across cultures, the team reviewed and provided feedback on this study protocol, including the burden on participants and constructs assessed. The CDC published a revised National DPP curriculum (2021 PreventT2) while the pilot trial was delayed due to the COVID-19 pandemic. Two additional meetings with 10 of the CAB members were held in June 2022. These meetings focused exclusively on content that was substantially changed in the 2021 curriculum revision.
An NIH Administrative Supplement was awarded in August 2022, providing funds for additional CAB meetings beyond those proposed in the parent grant. A meeting with eight members of the CAB was held in November 2022 to discuss recruitment processes and materials. During the pilot trial, the CAB will meet approximately every 3 months to provide feedback on initial feasibility data. Interested CAB members will be involved in communicating study findings to their respective communities and the broader public.
Trial design
Participating couples will be randomised (1:1) to one of two intervention conditions, an individual intervention condition (PreventT2) or the adapted couple-based intervention condition (PreventT2 Together). Regardless of the condition to which a couple is randomised, all participants will be invited to complete the same series of assessments. We used the CONSORT statement extension to randomised pilot and feasibility trials and associated checklist when preparing this report.38
Participants
Figure 1 presents the overall flow of participants through the study. As this is a pilot study, no sample size calculations were performed.38 Rather, we considered the number of couples that we thought could effectively participate in a single PreventT2 Together cohort. The CDC’s recommended cohort size is 10–15 individuals.39 Although study eligibility criteria (described below) are expected to yield a sample of couples who generally communicate and collaborate effectively, high levels of conflict within even one couple in the PreventT2 Together class could have a substantial negative impact on the overall group process. Consistent with this, a previous qualitative descriptive study of perspectives of Lifestyle Coaches who delivered the (individual) National DPP to dyads (ie, family members or friends together), found that 28% of Lifestyle Coaches identified difficult relationship dynamics as a challenge of a dyadic approach to diabetes prevention.22 We; therefore, determined an ideal couple-based cohort size of 6 couples, with 12 couples (24 individuals) in the full sample.
Figure 1.
Participant recruitment and assessment flow chart. This figure illustrates the flow of participants through recruitment, informed consent, randomisation and assessments.
Eligibility criteria: Participants will be adults eligible for the National DPP (ie, target individuals) and their romantic partners (ie, supporting partners). The supporting partner does not have to be eligible for the National DPP or otherwise meet the eligibility criteria set for the target individual, as detailed in table 1.
Table 1.
Participant eligibility criteria
| Inclusion | Exclusion |
| For target individuals only*: | For target individuals only: |
National DPP inclusion criteria:39
And
|
National DPP exclusion criteria:39
Study-specific exclusion criteria:
|
| For target individuals and supporting partners: | For target individuals and supporting partners: |
| Study-specific inclusion criteria: | Study-specific exclusion criteria: |
|
|
*The study team will not systematically screen supporting partners for National DPP eligibility. However, if a supporting partner seeks screening and does meet eligibility for the National DPP (ie, both partners in the couple are at high risk for type 2 diabetes), the supporting partner will not be prohibited from attending the National DPP themselves if the couple is randomised to the individual condition.
ADA, American Diabetes Association; BMI, body mass index; CDC, Centers for Disease Control and Prevention; DPP, Diabetes Prevention Programme.
Recruitment and Enrollment: Starting in July 2022, the research team sent contact persons at the University of Utah (including at Healthcare System Hospitals and Clinics (‘UHealth’), the National DPP and the Office of Research Participant Advocacy that hosts a Study Locator website) information on the study, encouraging self-referrals and provider-referrals. A number of UHealth outpatient clinics posted paper flyers and/or electronic advertisements with a QR code that linked to a research team webpage with additional information about the study and a contact form. Study advertisements were also posted on social media, including the research team’s Twitter, Facebook and Instagram accounts with reposting by university-owned accounts. Finally, the team posted flyers in community locations (eg, gyms, libraries, grocery stores, online message board) including local community-based organisations. Both the research team and interested CAB members participated in recruitment.
Potentially interested individuals contact (or are connected with) the University of Utah National DPP administrative assistant to determine National DPP eligibility via telephone or email (see table 1). The administrative assistant connects individuals who are eligible for the National DPP and interested in the study with the study coordinator for additional information and study-specific eligibility assessment via an online screening questionnaire. If eligible per the additional study criteria, participants will complete the informed consent process electronically. Participants will be encouraged to ask any questions before signing the consent document, and they may schedule a telephone call with the study coordinator.
Randomisation, blinding and treatment allocation
After completing the informed consent process, participating couples will be randomised to one of the intervention conditions using the National Cancer Institute’s Clinical Trial Randomisation Tool.40 A graduate research assistant (GRA) who is not involved in the screening process generated 12 randomised assignments to which no other team members have access. After the study coordinator enrolls a couple, the GRA shares the assignment with the study coordinator, who informs couples of the condition to which they are assigned. Given the nature of the study, participants and Lifestyle Coaches delivering the interventions will be unblinded to condition. However, research nurses collecting data in pre and post lab assessments will be blinded.
Interventions
This trial includes an individual and a couple-based intervention condition. The individual condition will use the CDC’s 2021 PreventT2 curriculum delivered to the target individual in the context of the University of Utah’s National DPP, which has ‘Full’ CDC recognition. The couple-based condition will use the adapted PreventT2 Together curriculum, which the CDC reviewed and approved as an alternate curriculum for the National DPP in November 2022. Consistent with CDC DPRP Standards,39 both interventions include 22+ classes delivered over the course of 12 months (February 2023–January 2024). Each intervention will be delivered by two Lifestyle Coaches who have completed standard National DPP training through a CDC-approved entity. Interventions will be delivered to small groups, including a group of target individuals in the individual condition, and a group of couples (including target individuals as well as supporting partners) in the couple-based condition. If a couple is randomised to the individual condition, the target individual may choose to invite the supporting partner to attend PreventT2 classes. This is allowable by the CDC and consistent with standard University of Utah National DPP operating procedures. We will track partner attendance at PreventT2 classes and will consider this in our feasibility evaluations. As required by the CDC, both curricula cover content relevant to diabetes prevention including methods for improving nutrition, increasing physical activity and losing weight. However, only PreventT2 Together includes content specific to couples with prompts encouraging partners to consider and discuss how they can best support one another and stories demonstrating how couples collaborated to make healthy lifestyle changes. See online supplemental table 1 for the participant objectives for each module across the two curricula.
bmjopen-2022-068623supp001.pdf (64.2KB, pdf)
As the CAB advised that virtual classes may not meet the needs of local adults from racial and ethnic groups that have been marginalised, we intend to deliver these classes in person unless public health guidelines dictate otherwise. However, in both conditions, participants will be offered make-up classes via online modules and individual (PreventT2) or couple (PreventT2 Together) meetings with a Lifestyle Coach. Lifestyle Coach fidelity will be ensured through regular supervision, which will be increased as needed to ensure fidelity. Both interventions will be delivered at University of Utah sites in the Salt Lake Valley, with those in the individual condition attending PreventT2 classes in the context of the University of Utah’s fully recognised National DPP, and those in the couple-based intervention attending PreventT2 Together outside of the context of the University of Utah programme. The individual condition Lifestyle Coaches will be employees of the University of Utah National DPP programme and supervised by the programme manager (EM), while the couple-based Lifestyle Coaches will be research team members supervised by the PI (KB). To promote engagement and retention, Lifestyle Coaches delivering the interventions across conditions will email participants regularly with reminders (eg, about the schedule of classes, with recaps of key information from classes) and additional tips for improving nutrition and physical activity. Lifestyle Coaches will also provide curriculum-based incentives (eg, yoga mats, measuring spoons) for participant engagement and attendance starting at month three of the interventions, per the University of Utah’s National DPP procedures.
Assessments
Figure 1 presents the flow of participants through the study. All participants across conditions will complete all assessments, except the following data will not be collected from supporting partners in couples randomised to the individual condition: (A) data collected at intervention classes and (B) data about intervention experiences. If supporting partners are eligible for the National DPP themselves, they will have the option of attending classes and these data would be collected. Participants will be compensated for completion of study assessments for a total of up to US$695.
Baseline and follow-up: Baseline physical activity will be objectively assessed for a 7-day period before the intervention using ActiGraph wGT3X-BT accelerometers. During this time, both target individuals and supporting partners will be instructed to individually wear accelerometers 24 hours/day. Participants will be sent a link to a 5 minute online questionnaire each evening for validation of the activity monitor data and additional self-report measures. This assessment will be repeated after the interventions (ie, follow-up).
Pre and Post Lab: Each participant will individually complete a 3-hour visit to the CTSI within 1 month of beginning and completing the interventions. During these visits, research nurses will conduct anthropometric measurements, draw blood for glucose tests and administer the 75 g oral glucose tolerance test. Each participant will privately complete online self-report questionnaires on a tablet during the assessment unless they completed the questionnaires from home prior to the lab visit.
Intervention classes: At each class in both conditions, weight and MVPA minutes will be collected, along with participant attendance. As noted above, these data will not be collected for supporting partners in couples randomised to the individual condition unless they are attending classes due to their own eligibility for the National DPP. In addition to the data collected from participants, Lifestyle Coaches delivering the couple-based intervention will complete a brief open-ended survey following each class.
Monthly: Beginning 1 month after the interventions begin, all participants will be asked to privately complete a monthly online questionnaire. Only participants attending classes will report on experiences in the interventions in this questionnaire.
Post Intervention Interview: We will also conduct 90 min audiorecorded joint couple interviews following completion of the intervention. A semistructured interview guide will be used by the PI (KB) to qualitatively assess couples’ experiences in the interventions and study, with a focus on feasibility.
Post Intervention Lifestyle Coach Survey: In addition to these data collected from participants, Lifestyle Coaches delivering the couple-based intervention will complete questionnaires.
Outcomes
Below are the prespecified measures the team will use to describe the feasibility of PreventT2 Together (objective 1) and the study protocol (objective 2). Given the uncertainty of estimates obtained in small pilot trials,41 we do not specify decision criteria for whether to proceed to a definitive trial. The determinations of whether to proceed to a definitive trial (vs additional piloting) and how to carry out next steps will be made together with the CAB after careful review of outcomes.
Objective 1a: Participants in couples randomised to the couple-based intervention condition will complete the Theoretical Framework of Acceptability-Based Questionnaire42 (TFA-BQ) and two open-ended survey items developed by the research team (What positive improvements have you noticed since the last class? What challenges did you face since the last class as you attempted to meet your goals?) in the Monthly and Post Questionnaire Assessments. Participant perspectives on the feasibility of PreventT2 Together will also be assessed in the Post Intervention Interview using a semistructured couple interview guide. Participant attendance, completion of weekly activity logs and completion of make-up sessions will be reported by the Lifestyle Coaches delivering the intervention.
Objective 1b: The Lifestyle Coaches delivering PreventT2 Together will complete a series of open-ended items developed by the research team following each class (What challenges arose with module delivery? What went well with module delivery? If you could re-write this module, what would you change?). After completion of the intervention, the Lifestyle Coaches will complete a measure of barriers to participation and lifestyle change observed among their participants25 as well as the Acceptability of Intervention Measure (AIM), Intervention Appropriateness Measure (IAM) and Feasibility of Intervention Measure (FIM)43 based on implementation outcomes.44
Objective 2: Participant perceptions of the study protocol will be assessed in the Post Intervention Interview using a semistructured couple interview guide. The guide includes specific prompts focused on recruitment (Tell me how you learnt about the study and what factors led the two of you to sign up), randomisation (In this study all couples were randomised to one of the two intervention conditions. How do you view that approach?), and the assessment protocol (Considering the frequency of assessments, how much time the assessments took and the compensation you received for that time, how do the two of you view the assessments overall?), as well as prompts about each type of assessment (ie, long (pre/post) and short (monthly, daily baseline/follow-up) online surveys, U of U CTSI Clinical Research Unit assessment, accelerometer wear, intervention class assessments (ie, weight, MVPA)) and for the questionnaires generally.
In addition to qualitative data on participants’ perspectives, data on recruitment feasibility (objective 2a) will be collected with an item in the contact form (How did you hear about our study? response options: social media, healthcare clinic/provider, other). Finally, participants will be invited to complete measures of health behaviours, physical and mental health, and relationship functioning detailed in table 2 (objective 2c), but are free to skip any items they do not wish to complete.
Table 2.
Domains of assessment
| Measures | Assessment time point | ||||
| Pre lab | Baseline | Monthly | Post lab | Follow-up | |
| Background | |||||
| Demographics* | X | ||||
| Adverse childhood experiences59 | X | ||||
| Health behaviours | |||||
| Physical activity | |||||
| IPAQ-Long60 | X | X | |||
| IPAQ-7 day60 | X | ||||
| Objectively assessed MVPA61 62 | X | X | |||
| Self-reported MVPA (past week) | X† | ||||
| Diet | |||||
| ASA-2463 | X | X | |||
| REAP-S64 | X | X | X | ||
| Sleep | |||||
| PROMIS Sleep Disturbance 8a59 | X | X | X | ||
| PROMIS Sleep-Related Impairment 8a65 | X | X | X | ||
| Daily Sleep Monitoring66 | X | X | |||
| Physical Health | |||||
| Height, waist circumference | X | X | |||
| Weight | X | X† | X | ||
| HbA1c, fasting blood glucose, 2 hours postglucose load | X | X | |||
| Mental Health | |||||
| PROMIS Anxiety 8a59 | X | X | X | ||
| PROMIS Depression 8a59 | X | X | X | ||
| Positive and Negative Affect Schedule67 | X | X | |||
| Relationship Functioning | |||||
| Relationship Satisfaction (CSI-4)68 | X | X | |||
| Daily Emotional and Instrumental Support69 70 | X | X | |||
| Relationship Satisfaction (CSI-16)68 | X | X | X | ||
| PAIR Sexual Intimacy Subscale71 | X | X‡ | X | ||
| Social Support and Exercise Survey72 | X | X‡ | X | ||
| Social Support and Eating Habits Survey72 | X | X‡ | X | ||
*Demographics include age, education, race/ethnicity, gender identity, marital status, income.
†Collected at each intervention class attended.
‡Administered every 3 months during the interventions (ie, months 3, 6 and 9).
ASA-24, Automated Self-Administered 24-Hour Dietary Assessment Tool; CSI-4, 4-item Couples Satisfaction Index; CSI-16, 16-item Couples Satisfaction Index; HbA1c, Hemoglobin A1c; IPAQ, International Physical Activity Questionnaire; MVPA, moderate-to-vigorous physical activity; PAIR, Personal Assessment of Intimacy in Relationships; PROMIS, Patient-Reported Outcomes Measurement Information System; REAP-S, Rapid Eating Assessment for Participants-Shortened.
Study withdrawal
Participants may inform the research team at any point in the study if they no longer wish to participate and do not want the research team to use their health information. If a participant decides to withdraw, we will not collect any new information about the participant, but we will continue to use information already collected, as needed to maintain the integrity of the research.
Serious adverse events
There are no expected adverse events. Any serious adverse event will be reported to the University of Utah IRB and NIDDK within 24 hours of the event, in accordance with the standard University of Utah IRB reporting guidelines.
Statistical methods
Quantitative measures of intervention feasibility (objective 1) and protocol feasibility (objective 2) will be summarised using descriptive statistics. Objective 1 quantitative measures include: participant reports on TFA-BQ; Lifestyle Coach reports of participant attendance, activity tracking completion and make-up session completion; and Lifestyle Coach reports on the AIM, IAM, FIM and barriers to participation and lifestyle change in the National DPP. Objective 2 quantitative measures include: the number of individuals from each of the three recruitment sources who contact the study team, and enroll in the study; the number of items from each measure that were skipped by participants; and the average length of time participants spent on each questionnaire assessment.
Qualitative measures will be collected from participants (ie, open-ended monthly survey items assessing Objective 1a and transcripts of interview responses to prompts assessing objectives 1a and 2a–2c after completing the intervention) as well as Lifestyle Coaches (ie, open-ended survey items after each PreventT2 Together class to assess objective 1b). The 90 min couple interview recordings will be professionally transcribed, and transcripts reviewed and verified by trained RAs on the study team. In a separate process within each objective, the text responses (surveys) or transcripts (interviews) will be carefully read and reread by the interviewer (KB), who has experience with qualitative coding and analysis. Inductive codes will be iteratively developed and evaluated using constant comparison. After codes are finalised, they will be sorted into categories of conceptually similar codes and the frequency of codes and categories will be summarised. This qualitative descriptive approach is common in health research broadly,45 and has been recommended in intervention work that aims to reduce health disparities specifically.46
Discussion
Although there are no studies of diabetes prevention interventions that have systematically incorporated romantic partners, meta-analyses have demonstrated family-based psychosocial interventions for adults with chronic illnesses are superior to individual interventions.18 As we describe below, there is preliminary support for the potential benefits of couple-based diabetes prevention. This study, with randomised allocation and blinded assessment, will examine the feasibility of the PreventT2 Together intervention package and the study protocol. Results will provide a foundation for a subsequent definitive RCT with the statistical power to directly test the overarching hypothesis that couple-based diabetes prevention will lead to improved engagement, outcomes and reach compared with the CDC’s individual curriculum.
Lack of family support is a critical barrier to National DPP participation.25 26 Involving significant others in the intervention may reduce this barrier and improve engagement. It is possible that individuals who would otherwise learn about but not enroll in the National DPP will be more likely to enroll, and that those who would otherwise enroll in but not complete the National DPP will be more likely to complete the programme, if they participate together with their romantic partner. There is support for higher engagement among those participating with other household members vs individually,47 but it has not specifically been examined in a romantic relationship context. As the National DPP has least effectively engaged individuals from groups that have been marginalised,15 increased engagement via a couple-based approach may reduce disparities.
Engaging romantic partners in diabetes prevention interventions may also improve outcomes for the at-risk partner who would otherwise participate individually. As greater retention and attendance are associated with increased likelihood of meeting the National DPP weight loss and physical activity goals,15 48 improved engagement through a couple-based approach may facilitate better outcomes. Additionally, the lifestyle factors targeted for intervention in the National DPP occur in a social context, and tend to be similar between partners within a couple.49 Changes in health behaviour at the couple level (eg, being physically active together, purchasing more nutritious foods when grocery shopping) may increase the likelihood of lifestyle change that is lasting. Consistent with this, spousal and family support facilitate greater health behaviour change in couple-based lifestyle intervention focused on management of type 2 diabetes,27 although this has not yet been examined in a type 2 diabetes primary prevention context.
In addition to the potential benefits for individuals aware of their risk for type 2 diabetes and the existence of the National DPP, a couple-based approach may also extend the reach and impact of the programme to other family members who are not aware of their risk. Estimates suggest over 80% of adults with pre-diabetes in the USA are not aware they have the condition.4 Even after controlling for similarity in lifestyle factors, one’s spouse having pre-diabetes increases one’s risk for incident diabetes.50 A couple-based approach may directly engage romantic partners who are at high risk for diabetes but would not otherwise be aware of their risk or reached by the National DPP. For couples with children and others living in the home, the approach may even have positive ‘ripple effects’ to the household members who are not participating in the intervention (eg, children), as demonstrated in previous weight loss intervention studies51 and observed by Lifestyle Coaches when delivering the National DPP to dyads (family members and/or friends).22
There are several important limitations to this planned study. First, as this pilot trial has a primary focus on feasibility, it is underpowered to examine the preliminary efficacy or effectiveness of the intervention. In addition to evaluating these intervention outcomes in a well-powered trial, future studies should evaluate implementation outcomes across levels of analysis beyond participants and the Lifestyle Coaches delivering the intervention (eg, at the level of the organisation or setting).44 Second, couple-based lifestyle intervention will not be indicated for all adults at risk for type 2 diabetes who are in romantic relationships.47 There is a well-documented cross-sectional association between lower relationship quality and poorer physical health,52 including increased risk for, and progression to, type 2 diabetes and cardiovascular disease.53 54 We anticipate the eligibility criteria of this trial will exclude couples with extremely low levels of relationship quality that would likely impede lifestyle change in a couple context. However, it will be critical for future work to examine the role of specific aspects of relationship functioning (eg, relationship satisfaction, support) that may moderate or mediate lifestyle change in a couple context. For people who do not have supportive and/or stable romantic partners, extending the National DPP to target other kinds of relationships (eg, peers, family members more broadly) may improve social support and subsequent outcomes.
Additionally, couples interested in participating in this study may desire to participate in PreventT2 Together, and random assignment to the individual condition may reduce motivation to complete the study. While those randomised to the individual condition will not be prohibited from participating in PreventT2 as a couple if desired, we may need to alter delivery of the control condition in the definitive trial. The feasibility data we collect on randomisation will guide our consideration of alternative control conditions. Finally, although a strength of this project is the close partnership with key stakeholders in adapting the intervention, further adaptation may be necessary to tailor the intervention for specific communities. Our changes are consistent with broad ‘surface structure’ adaptations to include representation and content that is relevant to couples across a wide range of communities and cultures.55 However, health beliefs and practices vary both between and within cultures.56 Interventions intended to target a specific community may require ‘deep structure’ adaptations that incorporate cultural norms, beliefs and values,55 57 or adaptative approaches that consider the variability within a given community.58 Despite these limitations, this study is an important first step that will apply existing knowledge from relationship science and principles of CBPR, extending the literature on innovative approaches to diabetes prevention.
Ethics and dissemination
This study protocol was reviewed and approved by the University of Utah IRB (#143079), which will approve all potential changes to the study (if applicable). Participants will complete the informed consent process prior to initiation of study procedures. Interested and eligible individuals will be provided with a written consent document that includes all study details, invited to have a phone call with study staff to discuss any questions, and encouraged to take the time they need to decide whether they wish to participate. Those interested will sign the consent form electronically.
The study team has established policies and procedures for data management. All data will be stored on encrypted external hard drives that are kept in a locked cabinet in the PI’s lab space as well as on encrypted servers. Participant identifiers will be stored separately from the coded participant data, with file access limited to only those team members who require the information.
Results will be shared with community stakeholders. We will work collaboratively with CAB members to identify the optimal strategy for sharing results within specific communities. Results will be shared with the research community through conference presentations and publications in peer-reviewed journals.
Supplementary Material
Acknowledgments
The authors would like to thank Heather Brown, Supi Mailei, Megan Monson, Louisa Stark, and Marc Wolfsfeld for their contributions to this project.
Footnotes
Contributors: Each author contributed significantly to the manuscript. MW, KB and MGC initially drafted and revised this manuscript. KB conceived of the research question. MCA and EB coordinated the CAB meetings, edited materials for the couple-based curriculum, and revised the draft manuscript. YBA, DG, KH, NK, JMU, EN, CR, FT-P, JV and CW suggested adaptations for the couple-based curriculum, provided feedback on the study design, and revised the draft manuscript. BW facilitated the CAB meetings, provided feedback on the study design, and revised the draft manuscript. EM. trained study staff, contributed to the study design and data acquisition, and revised the draft manuscript. KR contributed to the study design and revised the draft manuscript. DLS, TS, LC and TWS contributed substantially to the research question and study design, and revised the draft paper. All authors approved the final version submitted and participated sufficiently in the work to take public responsibility for appropriate portions of the content.
Funding: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the National Institutes of Health (grant numbers 5K23 DK115820-05, 3K23 DK115820-05S1 (PI: KB) and UL1TR002538).
Disclaimer: The contents of this publication are solely the responsibility of the authors and do not represent official views of the National Institutes of Health.
Competing interests: All authors have completed the ICMJE uniform disclosure form at http://www.icmje.org/disclosure-of-interest/ and declare: DG’s institution has received consulting fees from Medtronic, Abbott, Novo Nordisk, Sanofi, and Eli Lilly and Optum and DG was also a past president of Association of Diabetes Care and Education Specialists: Minnesota state chapter; KH is the programme coordinator for the Special Diabetes Program for Indians, has received travel and conference funds through the Urban Indian Center of Salt Lake, and is the planning committee co-chair for the Association of Diabetes Care and Education Specialists Utah Annual Diabetes Update Conference; KB is a Representative-at-Large on the Association for Behavioral and Cognitive Therapies Board of Directors and was a Member-at-Large on the Society for a Science of Clinical Psychology Board of Directors; no other relationships or activities that could appear to have influenced the submitted work.
Patient and public involvement: Patients and/or the public were involved in the design, or conduct, or reporting, or dissemination plans of this research. Refer to the Methods section for further details.
Provenance and peer review: Not commissioned; externally peer reviewed.
Supplemental material: This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.
Ethics statements
Patient consent for publication
Not applicable.
References
- 1.Matheus AS de M, Tannus LRM, Cobas RA, et al. Impact of diabetes on cardiovascular disease: an update. Int J Hypertens 2013;2013:653789. 10.1155/2013/653789 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Vigneri P, Frasca F, Sciacca L, et al. Diabetes and cancer. Endocr Relat Cancer 2009;16:1103–23. 10.1677/ERC-09-0087 [DOI] [PubMed] [Google Scholar]
- 3.National Center for Health Statistics . Leading causes of death. Cent Dis Control Prev 2019. Available: https://www.cdc.gov/nchs/fastats/leading-causes-of-death.htm [Google Scholar]
- 4.Centers for Disease Control and Prevention . National diabetes statistics report. US Dep Health Hum Serv 2022. Available: https://www.cdc.gov/diabetes/data/statistics-report/index.html [Google Scholar]
- 5.Diabetes Prevention Program Research Group . Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393–403. 10.1056/NEJMoa012512 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Diabetes Prevention Program Research Group . Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the diabetes prevention program outcomes study. Lancet Diabetes Endocrinol 2015;3:866–75. 10.1016/S2213-8587(15)00291-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Centers for Disease Control and Prevention . Prediabetes risk test [Natl Cent Chronic Dis Prev Health Promot]. Available: https://www.cdc.gov/diabetes/takethetest/ [Accessed 18 Aug 2022].
- 8.Hill-Briggs F, Adler NE, Berkowitz SA, et al. Social determinants of health and diabetes: a scientific review. Diabetes Care 2020;44:258–79. 10.2337/dci20-0053 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Mohebi R, Chen C, Ibrahim NE, et al. Cardiovascular disease projections in the united states based on the 2020 census estimates. J Am Coll Cardiol 2022;80:565–78. 10.1016/j.jacc.2022.05.033 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Kerrison G, Gillis RB, Jiwani SI, et al. The effectiveness of lifestyle adaptation for the prevention of prediabetes in adults: a systematic review. J Diabetes Res 2017;2017:8493145. 10.1155/2017/8493145 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Hamman RF, Wing RR, Edelstein SL, et al. Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care 2006;29:2102–7. 10.2337/dc06-0560 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Gruss SM, Nhim K, Gregg E, et al. Public health approaches to type 2 diabetes prevention: the US national diabetes prevention program and beyond. Curr Diab Rep 2019;19:78. 10.1007/s11892-019-1200-z [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Ely EK, Gruss SM, Luman ET, et al. A national effort to prevent type 2 diabetes: participant-level evaluation of CDC’s national diabetes prevention program. Diabetes Care 2017;40:1331–41. 10.2337/dc16-2099 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Jackson MC, Dai S, Skeete RA, et al. An examination of gender differences in the National diabetes prevention program’s lifestyle change program. Diabetes Educ 2020;46:580–6. 10.1177/0145721720964585 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Cannon MJ, Masalovich S, Ng BP, et al. Retention among participants in the National diabetes prevention program lifestyle change program, 2012-2017. Diabetes Care 2020;43:2042–9. 10.2337/dc19-2366 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.O’Brien MJ, Whitaker RC, Yu D, et al. The comparative efficacy of lifestyle intervention and metformin by educational attainment in the diabetes prevention program. Prev Med 2015;77:125–30. 10.1016/j.ypmed.2015.05.017 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Ritchie ND, Sauder KA, Phimphasone-Brady P, et al. Rethinking the National diabetes prevention program for low-income whites. Diabetes Care 2018;41:e56–7. 10.2337/dc17-2230 [DOI] [PubMed] [Google Scholar]
- 18.Martire LM, Schulz R, Helgeson VS, et al. Review and meta-analysis of couple-oriented interventions for chronic illness. Ann Behav Med 2010;40:325–42. 10.1007/s12160-010-9216-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Franks MM, Stephens MAP, Rook KS, et al. Spouses’ provision of health-related support and control to patients participating in cardiac rehabilitation. J Fam Psychol 2006;20:311–8. 10.1037/0893-3200.20.2.311 [DOI] [PubMed] [Google Scholar]
- 20.Troxel WM, Buysse DJ, Hall M, et al. Marital Happiness and sleep disturbances in a multi-ethnic sample of middle-aged women. Behav Sleep Med 2009;7:2–19. 10.1080/15402000802577736 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Ritchie ND, Baucom KJW, Sauder KA. Benefits of participating with a partner in the National diabetes prevention program. Diabetes Care 2020;43:e20–1. 10.2337/dc19-1489 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Baucom KJW, Bauman T, Nemirovsky Y, et al. Promises and pitfalls of dyads in the National diabetes prevention program: lifestyle coach perspectives. Am J Health Promot 2022;36:1204–7. 10.1177/08901171221088580 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Jiang L, Manson SM, Dill EJ, et al. Participant and site characteristics related to participant retention in a diabetes prevention translational project. Prev Sci 2015;16:41–52. 10.1007/s11121-013-0451-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Babatunde OA, Adams SA, Wirth MD, et al. Predictors of retention among African Americans in a randomized controlled trial to test the healthy eating and active living in the spirit (heals) intervention. Ethn Dis 2017;27:265–72. 10.18865/ed.27.3.265 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Baucom KJW, Bauman T, Gutierrez Chavez M, et al. Barriers to participation and lifestyle change among lower versus higher income participants in the National diabetes prevention program: lifestyle coach perspectives. Transl Behav Med 2022;12:860–9. 10.1093/tbm/ibac032 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Ritchie ND, Phimphasone-Brady P, Sauder KA, et al. Perceived barriers and potential solutions to engagement in the National diabetes prevention program. ADCES in Practice 2021;9:16–20. 10.1177/2633559X20966275 [DOI] [Google Scholar]
- 27.Gupta L, Khandelwal D, Lal PR, et al. Factors determining the success of therapeutic lifestyle interventions in diabetes-role of partner and family support. Eur Endocrinol 2019;15:18–24. 10.17925/EE.2019.15.1.18 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Wang C, Wu M, Yang YJ, et al. Effect and quality of couple-based interventions of middle-aged and older adults with type 2 diabetes mellitus: a scoping review. Fam Pract 2022;39:183–9. 10.1093/fampra/cmab093 [DOI] [PubMed] [Google Scholar]
- 29.Arden-Close E, McGrath N. Health behaviour change interventions for couples: a systematic review. Br J Health Psychol 2017;22:215–37. 10.1111/bjhp.12227 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Sher T, Braun L, Domas A, et al. The partners for life program: a couples approach to cardiac risk reduction. Fam Process 2014;53:131–49. 10.1111/famp.12061 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Nickel S, von dem Knesebeck O. Effectiveness of community-based health promotion interventions in urban areas: a systematic review. J Community Health 2020;45:419–34. 10.1007/s10900-019-00733-7 [DOI] [PubMed] [Google Scholar]
- 32.Salimi Y, Shahandeh K, Malekafzali H, et al. Is community-based participatory research (CBPR) useful? A systematic review on papers in A decade. Int J Prev Med 2012;3:386–93. [PMC free article] [PubMed] [Google Scholar]
- 33.Wallerstein N, Duran B. The theoretical, historical and practice roots of CBPR. Community-Based Particip Res Health Adv Soc Health Equity 2017:17–29. [Google Scholar]
- 34.Horowitz CR, Robinson M, Seifer S. Community-Based participatory research from the margin to the mainstream: are researchers prepared? Circulation 2009;119:2633–42. 10.1161/CIRCULATIONAHA.107.729863 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Newman SD, Andrews JO, Magwood GS, et al. Community Advisory boards in community-based participatory research: a synthesis of best processes. Prev Chronic Dis 2011;8:A70. [PMC free article] [PubMed] [Google Scholar]
- 36.Aguirre MC, Brown H, Gershenoff D, et al. The role of advocacy in adapting the diabetes prevention program for couple-based delivery that reaches marginalized groups. Behav Ther 2020;43:261. [PMC free article] [PubMed] [Google Scholar]
- 37.Eldridge SM, Lancaster GA, Campbell MJ, et al. Defining feasibility and pilot studies in preparation for randomised controlled trials: development of a conceptual framework. PloS One 2016;11:e0150205. 10.1371/journal.pone.0150205 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Eldridge SM, Chan CL, Campbell MJ, et al. CONSORT 2010 statement: extension to randomised pilot and feasibility trials. BMJ 2016;355:i5239. 10.1136/bmj.i5239 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.National Diabetes Prevention Program . Requirements for CDC recognition [Cent Dis Control Prev]. 2021. Available: https://www.cdc.gov/diabetes/prevention/requirements-recognition.htm
- 40.National Cancer Institute . Clinical trial randomization tool [Natl Inst Health]. Available: https://ctrandomization.cancer.gov/ [Accessed 18 Aug 2022].
- 41.Eldridge SM, Costelloe CE, Kahan BC, et al. How big should the pilot study for my cluster randomised trial be? Stat Methods Med Res 2016;25:1039–56. 10.1177/0962280215588242 [DOI] [PubMed] [Google Scholar]
- 42.Sekhon M, Cartwright M, Francis JJ. Development of a theory-informed questionnaire to assess the acceptability of healthcare interventions. BMC Health Serv Res 2022;22:279. 10.1186/s12913-022-07577-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Weiner BJ, Lewis CC, Stanick C, et al. Psychometric assessment of three newly developed implementation outcome measures. Implement Sci 2017;12:108. 10.1186/s13012-017-0635-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Proctor E, Silmere H, Raghavan R, et al. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm Policy Ment Health 2011;38:65–76. 10.1007/s10488-010-0319-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Kim H, Sefcik JS, Bradway C. Characteristics of qualitative descriptive studies: a systematic review. Res Nurs Health 2017;40:23–42. 10.1002/nur.21768 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Sullivan-Bolyai S, Bova C, Harper D. Developing and refining interventions in persons with health disparities: the use of qualitative description. Nurs Outlook 2005;53:127–33. 10.1016/j.outlook.2005.03.005 [DOI] [PubMed] [Google Scholar]
- 47.Baucom KJW, Ritchie ND. Including partners in the National diabetes prevention program: rationale and practical considerations. AADE Pract 2019;7:46–7. 10.1177/2325160319877569 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Ritchie ND, Baucom KJW, Sauder KA. Current perspectives on the impact of the National diabetes prevention program: building on successes and overcoming challenges. Diabetes Metab Syndr Obes 2020;13:2949–57. 10.2147/DMSO.S218334 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Kiecolt-Glaser JK, Wilson SJ. Lovesick: how couples’ relationships influence health. Annu Rev Clin Psychol 2017;13:421–43. 10.1146/annurev-clinpsy-032816-045111 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Leong A, Rahme E, Dasgupta K. Spousal diabetes as a diabetes risk factor: a systematic review and meta-analysis. BMC Med 2014;12:12. 10.1186/1741-7015-12-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Gorin AA, Lenz EM, Cornelius T, et al. Randomized controlled trial examining the ripple effect of a nationally available weight management program on untreated spouses. Obesity (Silver Spring) 2018;26:499–504. 10.1002/oby.22098 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Robles TF, Slatcher RB, Trombello JM, et al. Marital quality and health: a meta-analytic review. Psychol Bull 2014;140:140–87. 10.1037/a0031859 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Whisman MA, Uebelacker LA. A longitudinal investigation of marital adjustment as a risk factor for metabolic syndrome. Health Psychol 2012;31:80–6. 10.1037/a0025671 [DOI] [PubMed] [Google Scholar]
- 54.Whisman MA, Uebelacker LA, Settles TD. Marital distress and the metabolic syndrome: linking social functioning with physical health. J Fam Psychol 2010;24:367–70. 10.1037/a0019547 [DOI] [PubMed] [Google Scholar]
- 55.Resnicow K, Baranowski T, Ahluwalia JS, et al. Cultural sensitivity in public health: defined and demystified. Ethn Dis 1999;9:10–21. [PubMed] [Google Scholar]
- 56.Kagawa Singer M, Dressler W, George S, et al. Culture: the missing link in health research. Soc Sci Med 2016;170:237–46. 10.1016/j.socscimed.2016.07.015 [DOI] [PubMed] [Google Scholar]
- 57.Wang-Schweig M, Kviz FJ, Altfeld SJ, et al. Building a conceptual framework to culturally adapt health promotion and prevention programs at the deep structural level. Health Promot Pract 2014;15:575–84. 10.1177/1524839913518176 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Castro FG, Barrera M, Holleran Steiker LK. Issues and challenges in the design of culturally adapted evidence-based interventions. Annu Rev Clin Psychol 2010;6:213–39. 10.1146/annurev-clinpsy-033109-132032 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Cella D, Choi SW, Condon DM, et al. PROMIS® adult health profiles: efficient short-form measures of seven health domains. Value Health 2019;22:537–44. 10.1016/j.jval.2019.02.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Craig CL, Marshall AL, Sjöström M, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003;35:1381–95. 10.1249/01.MSS.0000078924.61453.FB [DOI] [PubMed] [Google Scholar]
- 61.Clevenger KA, Pfeiffer KA, Montoye AHK. Cross-generational comparability of hip- and wrist-worn actigraph GT3X+, wgt3x-BT, and GT9X accelerometers during free-living in adults. J Sports Sci 2020;38:2794–802. 10.1080/02640414.2020.1801320 [DOI] [PubMed] [Google Scholar]
- 62.Karaca A, Demirci N, Yılmaz V, et al. Validation of the actigraph wgt3x-BT accelerometer for step counts at five different body locations in laboratory settings. Measurement in Physical Education and Exercise Science 2022;26:63–72. 10.1080/1091367X.2021.1948414 [DOI] [Google Scholar]
- 63.Kirkpatrick SI, Subar AF, Douglass D, et al. Performance of the automated self-administered 24-hour recall relative to a measure of true intakes and to an interviewer-administered 24-h recall. Am J Clin Nutr 2014;100:233–40. 10.3945/ajcn.114.083238 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Segal-Isaacson CJ, Wylie-Rosett J, Gans KM. Validation of a short dietary assessment questionnaire: the rapid eating and activity assessment for participants short version (REAP-S). Diabetes Educ 2004;30:774–81. 10.1177/014572170403000512 [DOI] [PubMed] [Google Scholar]
- 65.Cella D, Riley W, Stone A, et al. Initial adult health item banks and first wave testing of the patient-reported outcomes measurement information system (PROMISTM) network: 2005–2008. J Clin Epidemiol 2010;63:11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Ancoli-Israel S, Martin JL, Blackwell T, et al. The SBSM guide to actigraphy monitoring: clinical and research applications. Behav Sleep Med 2015;13 Suppl 1:S4–38. 10.1080/15402002.2015.1046356 [DOI] [PubMed] [Google Scholar]
- 67.Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol 1988;54:1063–70. 10.1037//0022-3514.54.6.1063 [DOI] [PubMed] [Google Scholar]
- 68.Funk JL, Rogge RD. Testing the ruler with item response theory: increasing precision of measurement for relationship satisfaction with the couples satisfaction index. J Fam Psychol 2007;21:572–83. 10.1037/0893-3200.21.4.572 [DOI] [PubMed] [Google Scholar]
- 69.Dunkley DM, Zuroff DC, Blankstein KR. Self-critical perfectionism and daily affect: dispositional and situational influences on stress and coping. J Pers Soc Psychol 2003;84:234–52. 10.1037/0022-3514.84.1.234 [DOI] [PubMed] [Google Scholar]
- 70.Shrout PE, Herman CM, Bolger N. The costs and benefits of practical and emotional support on adjustment: a daily diary study of couples experiencing acute stress. Personal Relationships 2006;13:115–34. 10.1111/j.1475-6811.2006.00108.x [DOI] [Google Scholar]
- 71.Schaefer MT, Olson DH. Assessing intimacy: the pair inventory*. Journal of Marital and Family Therapy 1981;7:47–60. 10.1111/j.1752-0606.1981.tb01351.x [DOI] [Google Scholar]
- 72.Sallis JF, Grossman RM, Pinski RB, et al. The development of scales to measure social support for diet and exercise behaviors. Prev Med 1987;16:825–36. 10.1016/0091-7435(87)90022-3 [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
bmjopen-2022-068623supp001.pdf (64.2KB, pdf)

